Buy Blue Jet Healthcare; target of Rs 865: Motilal Oswal

Motilal Oswal is bullish on Blue Jet Healthcare recommended buy rating on the stock with a target price of Rs 865 in its research report dated April 30, 2025.

Broker Research

May 01, 2025 / 14:39 IST

Buy

26 Aug, 2025 12:21

Volume

Todays L/H

Motilal Oswal's research report on Blue Jet Healthcare

Greek philosopher Aristotle once said, “The secret to business is to know something that nobody else knows.” Blue Jet Healthcare (BLUEJET) is on the path to building a legacy business in line with this philosophy. With its niche product offerings in Contrast Media and Pharmaceutical Intermediaries & API, BLUEJET has been changing the way the healthcare industry caters to the therapeutic needs of patients around the globe. The company has established itself as a reliable supplier to its customers for the past three decades and is now working toward moving up the value chain by significantly increasing its investment in R&D.

Outlook

We expect FCF generation of INR3.6b during FY25-27E with cumulative capex of INR5b. The stock is trading at a P/E of ~28x on FY27E EPS of INR24.7 and FY27E Blue Jet Healthcare April 2025 5 EV/EBITDA of ~20x. We initiate coverage on BLUEJET with a BUY rating and a TP of INR 865, valuing the company at a P/E of 35x on FY27E EPS of INR24.7.

For all recommendations report, click here